Allakos
AcquiredSan Francisco, United States · Founded 2012 · $10.0M raised
- Headquarters
- San Francisco, California
- Employees
- 51–200
- Founded
- 2012
- Business Model
- B2B
- Website
- allakos.com
- Total Funding
- $10.0M
- Last Round
- $10.0M Series ADec 2012
- Rounds
- 1
About
Biotechnology company developing antibodies targeting receptors that modulate the activity of immune effector cells involved in inflammation and tissue damage.
Summary
Allakos is an Antibody Therapeutics company based in San Francisco, United States, founded in 2012. It has raised $10.0M in total across 1 round, most recently a $10.0M Series A round in Dec 2012.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2012
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...